Partners

The project involves a strategic collaboration with leading clinical partners in oncology and radiation oncology, enhancing its interdisciplinary nature and overall impact.

Affiliated Entities

Istituto Europeo di Oncologia (IEO)

Istituto Europeo di Oncologia (IEO)

The European Institute of Oncology (IEO) in Milan is a leading cancer research and treatment center, combining advanced clinical care with cutting-edge research in oncology, radiotherapy, and personalized medicine. IEO will contribute to WP3 and WP4 in the MINIONS project.

National Center for Oncological Hadrontherapy (CNAO)

National Center for Oncological Hadrontherapy (CNAO)

The National Center for Oncological Hadrontherapy (CNAO) in Pavia is a pioneering institute specializing in advanced radiotherapy treatments using proton and carbon ion therapy, integrating state-of-the-art clinical care with research in particle therapy. CNAO will contribute to WP3 and WP4 in the MINIONS project. 

Università di Padova (UniPD)

Università di Padova (UniPD)

The University of Padova is a prestigious academic institution renowned for excellence in research, education, and innovation. Its Department of Neurosciences conducts cutting-edge research on neurological diseases and rare head and neck tumors, combining basic and translational approaches to advance understanding and treatment. UniPD will contribute to WP4 in the MINIONS project. 

Collaborators

Azienda Ospedaliera di Padova (AOPD)

Azienda Ospedaliera di Padova (AOPD)

The Azienda Ospedaliera di Padova is a leading healthcare institution providing advanced clinical care and specialized treatments. It collaborates closely with the University of Padua, integrating clinical expertise with research in neurological diseases and rare head and neck tumors. AOPD will contribute to WP4 in the MINIONS project. 

IRCCS – Institute of Neurological Sciences in Bologna

IRCCS – Institute of Neurological Sciences in Bologna

The IRCCS Institute of Neurological Sciences in Bologna is a leading research and clinical center dedicated to the study and treatment of rare head and neck tumors. It combines advanced clinical care with cutting-edge research, integrating basic and translational approaches to improve patient outcomes. IRCCS Bologna will contribute to WP4 in the MINIONS project.

Chordoma Foundation

Chordoma Foundation

The Chordoma Foundation is an international nonprofit organization dedicated to supporting research, raising awareness, and improving care for patients with chordoma, a rare type of bone cancer. The foundation fosters collaboration among researchers, clinicians, and patients to advance understanding and treatment of the disease. 

Collaborating Projects

RAPTORplus

RAPTORplus

2026-2029

The RAPTORplus project, funded by the European Union’s Horizon 2020 Marie Skłodowska-Curie Actions, aims to revolutionize cancer treatment by advancing online adaptive particle therapy, including anatomical and biological adaptiation. The consortium comprises leading research institutions, academic hospitals, non-academic PT centers, industrial corporations, and public organizations across Europe. The CartCasLab of Politecnico di Milano is part of the consortium. 

PRECISION

PRECISION

2025-2026

The PRECISION project, funded by Italy’s National Recovery and Resilience Plan (PNRR) through the ANTHEM project, is a collaborative initiative led by the National Center for Oncological Hadrontherapy (CNAO) in Pavia, in partnership with the Politecnico di Milano and the MINIONS team. The project focuses on advancing particle therapy by integrating multi-parametric imaging and personalized modeling to enhance treatment accuracy and outcomes for patients with complex tumors. 

TAILOR

TAILOR

2021 - 2025

The TAILOR project – A technical framework for combining multi-parametric imaging with advanced modelling in personalized radiotherapy – funded by Associazione Italiana per la Ricerca contro il Cancro (AIRC), seeks to overcome current limitations in external-beam radiotherapy by integrating patient-specific multi-parametric imaging with advanced mathematical models to improve treatment-outcome prediction, enhance patient stratification, and enable more effective treatment optimization and personalization.